RIL
IOVA icon

Rothschild Investment LLC’s Iovance Biotherapeutics IOVA Stock Holding History

Rothschild Investment LLC’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
3,123
+2,334
+296% +$8.87K ﹤0.01% 1742
2026
Q1 		$2.77K Buy
789
+443
+128% +$1.42K ﹤0.01% 2388
2025
Q4 		$945 Sell
346
-4
-1% -$9 ﹤0.01% 2699
2025
Q3 		$760 Buy
350
+130
+59% +$307 ﹤0.01% 2698
2025
Q2 		$378 Sell
220
-10
-4% -$25 ﹤0.01% 2822
2025
Q1 		$766 Sell
230
-10
-4% -$52 ﹤0.01% 2479
2024
Q4 		$1.78K Sell
240
-30
-11% -$278 ﹤0.01% 1879
2024
Q3 		$2.54K Buy
270
+210
+350% +$1.99K ﹤0.01% 1603
2024
Q2 		$481 Buy
60
+40
+200% +$429 ﹤0.01% 2043
2024
Q1 		$296 Buy
+20
New +$233 ﹤0.01% 1563

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Rothschild Investment LLC's IOVA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Iovance Biotherapeutics (IOVA) stake by 296% in Q2 2026, buying an estimated $8.87K and bringing the position to 3,123 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1742.

Rothschild Investment LLC first reported a position in IOVA in Q1 2024 and has held it in 10 quarters since. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Rothschild Investment LLC held 3,123 shares of Iovance Biotherapeutics worth $13K as of Q2 2026.
  • Rothschild Investment LLC bought 2,334 Iovance Biotherapeutics shares in Q2 2026, an estimated $8.87K.
  • Iovance Biotherapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1742 holding.
  • Rothschild Investment LLC first reported a position in Iovance Biotherapeutics in Q1 2024 and has held it in 10 quarters since.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.